Hybridomas obtained from (NFS x AKR)F1 mice immunized with syngeneic cells infected with AKR-247 MCF virus produced antibodies specific for only AKR-247 or closely related MCF viruses which share a previously defined MCF antigen . These monoclonal antibodies recognized a new type of viral antigenic determinant which appeared to be a conformational determinant associated with the env precursor polyprotein (pr8Oe"v) or its disulfide-linked gp7O-p15(E) complex (gp8O) but not with free gp7O or p15(E) or any other virion or virus-induced protein.
Within the genome of the mouse are gene sequences coding for, or related to, a variety of RNA type C viruses (3, 14, 21) . In the infectious form, these endogenous murine leukemia viruses (MuLV) (2, 9, 20) . Biologically they exhibit new properties in comparison to ecotropic or xenotropic viruses, including, for some MCFs, the capacity to induce lymphomas in certain strains of mice (7, 18) .
Serological characterization of MCF viruses has been accomplished by using heterologous (rabbit) (6, 12) and homologous (mouse) (24) antisera. The studies with rabbit antisera showed that MCF viruses possess ecotropic-, xenotropic-, and several MCF-specific antigens, whereas murine antibodies to MCF virus appear to be more restricted. The G(AKSL2) MCF-specific antigen defined by natural murine antiserum (24) , in fact, appeared to be different from any of the specificities defined by rabbit antibodies.
A somewhat different and, in some cases, a more detailed analysis of antigenic specificity can be accomplished by characterizing monoclonal antibodies obtained from immunized animals. This approach was used in this study to analyze antibodies obtained from (NFS x AKR)F1 mice immunized against AKR-247 MCF virus. These mice were previously shown to mount a strong humoral immune response to AKR-247 MCF virus, but this response appeared to be ineffective in preventing the induction of lymphoma (8) . It was therefore of interest to further study these antibodies.
At 2 to 5 days of age, (NFS/N x AKR/J)F1 mice, bred at the Rocky Mountain Laboratories, were injected in the region of the thymus with approximately 103 4 mink cell focus-forming units of thymotropic AKR-247 MCF virus. After 6 weeks, when MCF virus replication in the thymus had reached a high level, thymuses were removed, the cells were dissociated in medium without serum, and 5 x 107 cells were injected intravenously into 6-week-old syngeneic F1 recipients. After 2 weeks, spleens from recipients were removed and fused with HAT-sensitive NS1 myeloma cells by the technique of Kohler and Milstein (15) as described in detail elsewhere (4).
Hybridoma clones obtained were screened for the production of antiviral antibodies by reacting culture supernatants in indirect membrane immunofluorescence on cells infected with ecotropic, xenotropic, amphotropic, and MCF viruses as described previously (5, 6 Fig. 1 ). Hy-40 precipitated under nonreducing conditions an 80-kilodalton protein from Nonidet P-40 (NP-40) lysates of 121I-labeled AKR-247 MCF virus or labeled surface proteins of infected cells. This protein was also precipitated by antibodies to p15(E) and gp7O ( Fig. 1, left panel) . It has been shown that this 80-kilodalton protein is a complex of two envelope proteins, gp7O and p15(E), which exists either as an uncleaved precursor molecule, pr80e"v, or as a cleaved but disulfide-linked complex of gp7O and p15(E) (gp8O) (10, 17, 19) . Work by Pinter et al. has further indicated that gp7O and p15(E) do not naturally exist in the virion membranes as the disulfide-linked complex (gp8O), but rather they spontaneously form this complex after the disruption of the virion by nonionic detergents (19) . Although Hy-40 reacted with the 80-kilodalton protein, it did not precipitate free gp70, even though the presence of gp7O was demonstrated by precipitation with goat antiserum to gp7O or an anti-gp70 hybridoma. Free p15(E) was not demonstrated, since it is not labeled by iodination (16); the monoclonal antibody specific for p15(E) precipitated the pr8Oe"v or gp8O polypro- 5% 2-mercaptoethanol (2-ME). They were electrophoresed in 10% polyacrylamide slab gels in the presence of SDS at 25 mA per gel for 3 h. The gels were stained with Coomassie brilliant blue, fixed, destained, and dried. Autoradiography was carried out with Kodak X-Omat R film at -70°C, employing intensifying screens. The following antibodies used to precipitate were: (A) anti-plS(E) hybridoma (372), 0.5 ml (4); (B) anti-247 hybridoma (Hy-40), 0.1 ml; (C) anti-247 hybridoma (Hy-40), 0.5 ml; (D) anti-gp7O hybridoma (18-1), 0.5 ml (manuscript in preparation); and (E) goat anti-R MuLV gp7O, 5 ,ul (4) . tein owing to their p15(E) components. Treatment of the immunoprecipitates with 2-mercaptoethanol to reduce disulfide linkages (Fig. 1,  right There could be several reasons why an antigenic determinant may exist on a precursor molecule but not on its known cleaved and separated products. One possibility is that the determinants in question may be conformational, determined by secondary or tertiary structure unique to the precursor molecule or complexed gp70-pl5(E). A similar phenomenon has been seen with antibodies to staphylococcal nuclease which recognized an antigenic determinant formed by the combination and folding of separate polypeptide fragments (23) . Another possibility may be that an additional polypeptide covalently bound to the envelope precursor is being recognized. Such a polypeptide, designated as the R protein, has been identified in some MuLV systems, and antibodies to it immunoprecipitate both the envelope precursor and the free R protein (25) . The MCF-specific monoclonal antibodies probably do not recognize such a protein, since (i) they recognize, in addition to pr8Oenv, the cleaved but complexed gp8O, and (ii) they do not immunoprecipitate a small R protein. The a Surviving fraction of virus activity after the neutralization reaction. Equal volumes of hybridoma fluid, or diluted antiserum or medium as the control, were mixed with virus (approximately 100 to 200 focus-forming units). Medium or guinea pig complement (dilution 1:6) at one-fourth the volume of the reaction mixture was then added, and the mixture was incubated 1 h at room temperature. We then added 0.2 ml of the mixture to 60-mm dishes containing mink (ATCC CCL64) or SC-1 cells, plated at 2 x 105 cells 24 h earlier, and medium containing 8 ,ug of Polybrene per ml. The medium was changed the next day; ecotropic virus was scored by the UV-XC procedure on the SC-1 cells, and MCF virus was scored by focus formation in the mink cell monolayers as described previously (13, 22) .
b Sucrose gradient purified virus was diluted in TNE (0.01 M Tris-hydrochloride [pH 7.2], 0.14 M NaCl, and 0.001 M EDTA) (optimum dilution determined by titration) and adsorbed to wells offlexible polyvinyl microtiter trays by incubating overnight at 4°C. The wells were then washed three times and incubated for 30 min with phosphate-buffered saline containing 0.5% gelatin, which blocked further protein adsorption. We added 50 ,ul of hybridoma supernatants or diluted antiserum to the wells, which were incubated for 30 min at 37°C, and then added, for 30-min incubations, 50 RI1 of diluted rabbit anti-mouse immunoglobulin followed by 125I-labeled protein A (approximately 100,000 cpm), respectively. Wells were washed three times with phosphate-buffered saline containing 0.5% gelatin between each and after the final incubation. The amount of binding was determined by drying and cutting the wells from the tray and counting them in a gamma counter. Data are presented as a binding index: (average counts per minute antibody -average counts per minute of control)/ (average counts per minute of control).
to cells infected with C58L1 and CB208 MCF viruses, whereas the other monoclonals extensively bound to these cells. This may indicate that different determinants of the gp7O-pl5(E) complex were being recognized by different monoclonal antibodies.
Direct presentation of the gp7O-pl5(E) determinant(s) to spleen cells appeared to be required to subsequently obtain hybridomas. The hybridomas reported herein were only obtained after intravenous injection of MCF-infected cells, some of which end up in the spleen. Four attempts to make hybridomas from spleens of mice that were immunized with MCF virus alone were unsuccessful. It is likely that infected cells express large amounts of gp8O and would be very efficient for immunization. In addition, this virus is specifically thymotropic and does not infect spleen cells (7), so injecting this virus into mice may be expected to be a poor way to stimulate splenic B lymphocytes.
The monoclonal antibodies described in this report appear similar to the majority of mouse serum antibodies detected after immunization with AKR-247 MCF virus (manuscript in preparation). NFS antisera predominantly contain MCF-specific antibodies with very minor specificities for ecotropic virus. The MCF-specific determinant(s) recognized by the murine monoclonal antibodies is expressed by the same MCF viruses that express the previously described MCFA-3 antigen (6). This antigen was defined by rabbit antisera, and preliminary evidence indicates that rabbit MCFA-3 specific antibody, similarly to the mouse monoclonals, preferentially immunoprecipitates pr80env and gp80, but not gp7O or p15(E) (unpublished data).
